195 related articles for article (PubMed ID: 15082764)
41. Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression.
Raught B; Liao WS; Rosen JM
Mol Endocrinol; 1995 Sep; 9(9):1223-32. PubMed ID: 7491114
[TBL] [Abstract][Full Text] [Related]
42. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved.
Jover R; Bort R; Gómez-Lechón MJ; Castell JV
FASEB J; 2002 Nov; 16(13):1799-801. PubMed ID: 12354697
[TBL] [Abstract][Full Text] [Related]
43. Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300.
Jakobs A; Steinmann S; Henrich SM; Schmidt TJ; Klempnauer KH
J Biol Chem; 2016 Dec; 291(50):26098-26108. PubMed ID: 27803164
[TBL] [Abstract][Full Text] [Related]
44. CCAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPdelta contribute to growth hormone-regulated transcription of c-fos.
Liao J; Piwien-Pilipuk G; Ross SE; Hodge CL; Sealy L; MacDougald OA; Schwartz J
J Biol Chem; 1999 Oct; 274(44):31597-604. PubMed ID: 10531366
[TBL] [Abstract][Full Text] [Related]
45. C/EBPβ LIP and c-Jun synergize to regulate expression of the murine progesterone receptor.
Wang W; Do HN; Aupperlee MD; Durairaj S; Flynn EE; Miksicek RJ; Haslam SZ; Schwartz RC
Mol Cell Endocrinol; 2018 Dec; 477():57-69. PubMed ID: 29870755
[TBL] [Abstract][Full Text] [Related]
46. CCAAT-enhancer-binding protein beta activation of MMP-1 gene expression in SW1353 cells: independent roles of extracellular signal-regulated and p90/ribosomal S6 kinases.
Petrella BL; Armstrong DA; Vincenti MP
J Cell Physiol; 2011 Dec; 226(12):3349-54. PubMed ID: 21344389
[TBL] [Abstract][Full Text] [Related]
47. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice.
Harrison JR; Huang YF; Wilson KA; Kelly PL; Adams DJ; Gronowicz GA; Clark SH
J Biol Chem; 2005 Mar; 280(9):8117-24. PubMed ID: 15598659
[TBL] [Abstract][Full Text] [Related]
48. Expression, hormonal regulation, and subcellular localization of CCAAT/enhancer-binding protein-beta in rat and human thyrocytes.
Pomérance M; Mockey M; Young J; Quillard J; Blondeau JP
Thyroid; 2005 Mar; 15(3):197-204. PubMed ID: 15785238
[TBL] [Abstract][Full Text] [Related]
49. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
Bundy LM; Sealy L
Oncogene; 2003 Feb; 22(6):869-83. PubMed ID: 12584567
[TBL] [Abstract][Full Text] [Related]
50. CUG-BP1 regulates RyR1 ASI alternative splicing in skeletal muscle atrophy.
Tang Y; Wang H; Wei B; Guo Y; Gu L; Yang Z; Zhang Q; Wu Y; Yuan Q; Zhao G; Ji G
Sci Rep; 2015 Nov; 5():16083. PubMed ID: 26531141
[TBL] [Abstract][Full Text] [Related]
51. Expression and DNA-binding activity of C/EBPalpha and C/EBPbeta in human liver and differentiated primary hepatocytes.
Ferrini JB; Rodrigues E; Dulic V; Pichard-Garcia L; Fabr JM; Blanc P; Maurel P
J Hepatol; 2001 Aug; 35(2):170-7. PubMed ID: 11580138
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
Phatak P; Byrnes KA; Mansour D; Liu L; Cao S; Li R; Rao JN; Turner DJ; Wang JY; Donahue JM
Oncogene; 2016 Apr; 35(16):2087-97. PubMed ID: 26234674
[TBL] [Abstract][Full Text] [Related]
53. Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3.
Tsuda K; Kuwasako K; Takahashi M; Someya T; Inoue M; Terada T; Kobayashi N; Shirouzu M; Kigawa T; Tanaka A; Sugano S; Güntert P; Muto Y; Yokoyama S
Nucleic Acids Res; 2009 Aug; 37(15):5151-66. PubMed ID: 19553194
[TBL] [Abstract][Full Text] [Related]
54. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz.
Kang KW; Cho IJ; Lee CH; Kim SG
J Natl Cancer Inst; 2003 Jan; 95(1):53-66. PubMed ID: 12509401
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein).
Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
Mol Pharmacol; 2005 Jun; 67(6):2088-101. PubMed ID: 15778453
[TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.
Choy L; Derynck R
J Biol Chem; 2003 Mar; 278(11):9609-19. PubMed ID: 12524424
[TBL] [Abstract][Full Text] [Related]
57. Cell transformation results in the loss of the density-dependent translational regulation of the expression of fibroblast growth factor 2 isoforms.
Galy B; Maret A; Prats AC; Prats H
Cancer Res; 1999 Jan; 59(1):165-71. PubMed ID: 9892202
[TBL] [Abstract][Full Text] [Related]
58. Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells.
Christian M; Pohnke Y; Kempf R; Gellersen B; Brosens JJ
Mol Endocrinol; 2002 Jan; 16(1):141-54. PubMed ID: 11773445
[TBL] [Abstract][Full Text] [Related]
59. Stress activation of mammary epithelial cell xanthine oxidoreductase is mediated by p38 MAPK and CCAAT/enhancer-binding protein-beta.
Seymour KJ; Roberts LE; Fini MA; Parmley LA; Oustitch TL; Wright RM
J Biol Chem; 2006 Mar; 281(13):8545-58. PubMed ID: 16452486
[TBL] [Abstract][Full Text] [Related]
60. Decreased expression of insulin-like growth factor binding protein-5 during N-(4-hydroxyphenyl)retinamide-induced neuronal differentiation of ARPE-19 human retinal pigment epithelial cells: regulation by CCAAT/enhancer-binding protein.
Samuel W; Kutty RK; Vijayasarathy C; Pascual I; Duncan T; Redmond TM
J Cell Physiol; 2010 Sep; 224(3):827-36. PubMed ID: 20583135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
